Pomalidomide 4mg capsules
NHS hospitals in England used £41,544,997 of indicative cost of Pomalidomide 4mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 15.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Pomalidomide 4mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Pomalidomide 4mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £1,729,418 |
| The Royal Marsden Nhs Foundation Trust | £1,397,749 |
| Norfolk & Norwich University Hpl Nhs Trt | £1,368,559 |
| Imperial College Healthcare Nhs Trust | £1,279,719 |
| University College London Foundation Tr | £1,223,491 |
| East And North Hertfordshire Nhs Trust | £1,154,920 |
| Royal Cornwall Hospitals Nhs Trust | £904,899 |
| Derby Teaching Hospitals Nhs Found Trust | £897,284 |
| North Bristol Nhs Trust | £879,516 |
| Southend Univ Hosp Nhs Foundation Trust | £870,632 |
The primary-care picture
Pomalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Pomalidomide medicine page.